https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/glenmark-specialty-sa-signs-license-agreement-with-jiangsu-alphamab-3d-medicines-for-envafolimab/107141838
Glenmark Specialty SA signs license agreement with Jiangsu Alphamab, 3D Medicines for Envafolimab,...
Under the terms of the agreement, GSSA will receive from Jiangsu Alphamab and 3DMed, an exclusive license to develop, register, commercialise, Envafolimab for...